The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

ANIK FINANCIAL STATEMENTS

Anika Therapeutics Inc — balance sheet, income statement and cash flow trends

ANIKAnika Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-100 M0100 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue120.7 M $Gross Profit75 M $ · 62%Operating Income-5.1 M $ · -4%Pre-tax Income-2.9 M $ · -2%Net Income to Owners-3.8 M $ · -3%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue120.7 M $+31.4%
Gross Profit75 M $+41.4%
Operating Income-5.1 M $—
EBITDA2.7 M $—
Net Income to Owners-3.8 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets183.5 M
  • Equity137.3 M $75%
  • Current Liabilities22.1 M $12%
  • Long-term Liabilities24 M $13%

Key Figures

YoY change
Total Assets183.5 M $-2.2%
Total Liabilities46.2 M $+15.5%
Total Equity137.3 M $-7.0%
Cash & ST Investments38.4 M $-27.8%
Total Debt23.3 M $-6.7%
Net Debt-15.1 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-10 M010 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-10 M06 M $Operating-4.1 M $Investing-16.3 M $Financing-14.4 M $Net Change

Key Figures

YoY change
Operating Cash Flow6 M $-4.8%
Capital Expenditures5.4 M $-27.0%
Free Cash Flow562 K $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on ANIK

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.